MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • 2026 International Congress

    Interventions in Friedreich’s Ataxia and their Influence on Patient-centric Outcomes: A Systematic Review

    D. Sarwinska, M. Buchholz, A. Iskandar, M. Grobe-Einsler, T. Klockgether, J. Faber, B. Michalowsky (Greifswald, Germany)

    Objective: The presented systematic review summarizes available pharmacological and non‑pharmacological interventions for patients with Friedreich's ataxia, their outcomes, and alignment with patient‑centered health domains as…
  • 2026 International Congress

    The Therapeutic Landscape of SSPE: A Systematic Review of Antiviral and Immunomodulatory Modalities

    V. Jadhav, S. Errabelly, M. Tripathi, D. Dash, P. Mohapatra, E. Arunmozhimaran (New Delhi, India)

    Objective: To systematically map the global therapeutic landscape of SSPE interventions, specifically characterizing drug regimens, dosages, administration routes, and monotherapy versus combination protocols. Background: SSPE…
  • 2026 International Congress

    Digital cognitive training and promoting a healthy lifestyle as a booster for cognitive reserve in prodromal Parkinson’s disease?

    A. Ophey, S. Röttgen, K. Kufer, J. Pauquet, D. Scharfenberg, P. Armbrust, A. Kammerzell, N. Knopf, S. Kollath, P. Sommer, CEJ. Doppler, E. Farrher, A. Seger, NJ. Shah, D. Zopfs, K. Reetz, GR. Fink, M. Sommerauer, E. Kalbe (Cologne, Germany)

    Objective: To investigate predictors of responsiveness to a multimodal cognitive training intervention in individuals with isolated REM sleep behavior disorder (iRBD). Background: The prodromal phase…
  • 2026 International Congress

    Slow-SPEED-US: Initiation of a Remote Exercise Trial in LRRK2 and GBA1 Carriers

    R. Schneider, T. Oosterhof, E. Prins, M. Kmiecik, S. Aslibekyan, N. Hetrick, M. Porto, K. Schmier, C. Dorney, A. Noyce, B. Bloem, S. Darweesh (Rochester, USA)

    Objective: To describe the launch of Slow-SPEED-US, presenting recruitment results and baseline characteristics of the enrolled subsample. Background: Slow-SPEED-US is part of a network of…
  • 2026 International Congress

    EAGLE: Protocol for a Phase 3 Study to Evaluate the Efficacy and Safety of Two Mobile Applications Combined with Immediate-Release CD/LD for the Management of Idiopathic Parkinson’s Disease

    S. Oren, A. Amedi, S. Molcho, D. Ziv, O. Shoval, S. Erlich (Ramat Gan, Israel)

    Objective: To evaluate the efficacy and safety of Hybridopa A and Hybridopa B, combination products of immediate-release carbidopa/levodopa (IR CD/LD) and therapeutic mobile applications, in adults with idiopathic Parkinson’s disease (PD) on a…
  • 2026 International Congress

    The Effects of Bright Light Therapy on Improving Sleep Disorders in Parkinson’s Disease

    WY. Xie, JM. Duan, WX. Duan, Y. Chen, F. Wang, Y. Shen, CF. Liu (Suzhou, China)

    Objective: To explore the effects of bright light therapy (BLT) on improving sleep disorders in Parkinson‘s disease (PD). Background: Sleep disorders are common clinical symptoms…
  • 2026 International Congress

    Barriers and Enablers to Diversity and Inclusion in Movement Disorders Research (BIND-MD)

    H. Collins, E. Manoharan, S. Gandhi, A. Zarkali, A. Batla (London, United Kingdom)

    Objective: BIND-MD aims to identify barriers that hinder participation of ethnic minorities in movement disorders research, examine sources of mistrust and develop strategies to overcome…
  • 2026 International Congress

    Slow-SPEED UK: A Double-Blind Randomised Feasibility Trial of a Remote Gamified Physical Activity Programme in Adults with Hyposmia

    V. Azoidou, T. Oosterhof, E. Mitchell, B. Bloem, C. Philpott, S. Darweesh, A. Noyce (London, United Kingdom)

    Objective: To evaluate the feasibility, adherence, acceptability, and safety of a long-term, fully remote, gamified physical activity intervention in adults with objectively confirmed hyposmia, and…
  • 2026 International Congress

    ALPHA-FIT: Slowing cognitive decline in alpha-synucleinopathies by enhancing physical activity

    E. Fitzgibbon, M. Wildt, T. Oosterhof, M. Rodemann, A. Ophey, E. Prins, S. Darweesh, A. Stefani, M. Sommerauer (Bonn, Germany)

    Objective: To evaluate the effects of increased physical activity on cognitive decline in patients with isolated REM sleep behavior disorder (iRBD). Background: Physical activity has…
  • 2026 International Congress

    Impact of Hula on Balance Outcomes in Parkinson’s Disease

    M. Yee, P. Young, R. Shuman, C. Stickley, M. Bruno (Honolulu, USA)

    Objective: This study aims to determine the impact of a 12-week Hula program on balance in patients with Parkinson’s Disease (PD) and to investigate changes…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 29
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley